Pulmonary artery pressure monitoring in chronic heart failure: effects across clinically relevant subgroups in the MONITOR-HF trial.
Clephas PRD, Zwartkruis VW, Malgie J, van Gent MWF, Brunner-La Rocca HP, Szymanski MK, van Halm VP, Handoko ML, Kok WEM, Asselbergs FW, van Kimmenade RRJ, Manintveld OC, van Mieghem NMDA, Beeres SLMA, Post MC, Borleffs CJW, Tukkie R, Mosterd A, Linssen GCM, Spee RF, Emans ME, Smilde TDJ, van Ramshorst J, Kirchhof CJHJ, Feenema-Aardema MW, da Fonseca CA, van den Heuvel M, Hazeleger R, van Eck M, van Heerebeek L, Boersma E, Rienstra M, de Boer RA, Brugts JJ.
Clephas PRD, et al. Among authors: szymanski mk.
Eur Heart J. 2024 Aug 21;45(32):2954-2964. doi: 10.1093/eurheartj/ehae323.
Eur Heart J. 2024.
PMID: 38733175
Free PMC article.
Clinical Trial.